Beta Bionics, Inc. (BBNX) vs Pacific Biosciences of California, Inc. (PACB)

A side-by-side comparison of Beta Bionics, Inc. and Pacific Biosciences of California, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Beta Bionics, Inc. logo
BBNX
Beta Bionics, Inc.
$838M
$18.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Pacific Biosciences of California, Inc. logo
PACB
Pacific Biosciences of California, Inc.
$839M
$2.70HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BBNX vs PACB

growth of $100 · dividends reinvested · last 2y
BBNX -19.8% (-10.4%/yr)PACB +84.0% (+35.6%/yr)PACB compounded faster over this window
50100150Start $1002026$80$184
BBNX PACB

BBNX vs PACB: by the numbers

  • •PACB is the larger company ($839M vs $838M market cap).
  • •Both run net losses; BBNX's is the smaller (-61.32% vs -82.49% net margin).

Metrics side by side

Valuation

MetricBBNXPACB
P/S ratio7.045.27
P/B ratio3.27N/A

Profitability

MetricBBNXPACB
Gross margin58.31%35.97%
Operating margin-69.75%-348.46%
Net margin-61.32%-82.49%
ROE-28.46%N/A
ROIC-31.17%-23.80%

Growth (annualized)

MetricBBNXPACB
Revenue CAGR (5Y)N/A8.52%
Total return CAGR (5Y)N/A-35.20%

Go deeper

Full BBNX analysisFull PACB analysisInteractive comparison tool

Dig into the metrics

Beta Bionics ROEPacific Biosciences of California ROEBeta Bionics operating marginPacific Biosciences of California operating marginBeta Bionics revenue growthPacific Biosciences of California revenue growthBeta Bionics free cash flowPacific Biosciences of California free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.